Massive weight gain and hostility force mirtazapine stoppage [1]

Canadian Journal of Psychiatry

Volumn 47, Issue 6, 2002, Pages 582-

  Abraham, G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; CLOMIPRAMINE; MIRTAZAPINE; PAROXETINE; VENLAFAXINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DEPRESSION; DRUG MECHANISM; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; LETTER; PHYSICAL DISABILITY; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0036695038     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370204700617     Document Type: Letter

References (6)

1. Mirtazapine: Clinical advantages in the treatment of depression
2. Tolerability and patient compliance
3. Meta-analysis of randomized, double blind, placebo controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression
4. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression
5. Mirtazapine in major depression with comorbid general anxiety disorder
6. Mirtazapine, an antidepressant